Literature DB >> 14739341

Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.

Sheryl S Justice1, Chia Hung, Julie A Theriot, Daniel A Fletcher, Gregory G Anderson, Matthew J Footer, Scott J Hultgren.   

Abstract

Uropathogenic Escherichia coli (UPEC) are capable of forming complex intracellular bacterial communities (IBC) within the superficial umbrella cells of the bladders of C3H and BALB/c mice. By using time-lapse fluorescence videomicroscopy to observe infected mouse bladder explants, we discovered that IBCs formed by uropathogenic E. coli progressed through four distinct developmental stages that differed with respect to growth rate, bacterial length, colony organization, motility, and its eventual dispersal. In the first phase, bacteria in the IBC were nonmotile, rod shaped, and grew rapidly in loosely organized colonies free in the cytoplasm of the bladder superficial umbrella cells. In the second phase, the loose collection of bacteria in the IBC matured into a slower growing, highly organized biofilm-like community consisting of coccoid bacteria that ultimately filled most of the cytoplasm. In the third phase, bacteria in the biofilm-like state in the IBC switched to a motile rod-shaped phenotype allowing detachment from the community and eventual fluxing out of the host cell. During the fourth phase, the bacteria filamented. Filamentation appeared to be in response to a Toll-like receptor 4-mediated innate defense mechanism. Bacteria that fluxed out of the superficial umbrella cells were able to reenter the IBC developmental cascade but with slower kinetics and ultimately a quiescent reservoir was established. Intracellular growth and filamentation provided an advantage to the bacteria in evading infiltrating polymorphonuclear leukocytes. This work has developed a technique to observe live infected organs and revealed a complex differentiation pathway that facilitates bacterial persistence in the urinary tract.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14739341      PMCID: PMC337053          DOI: 10.1073/pnas.0308125100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli.

Authors:  Indira U Mysorekar; Matthew A Mulvey; Scott J Hultgren; Jeffrey I Gordon
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

2.  Escherichia coli-induced inducible nitric oxide synthase and cyclooxygenase expression in the mouse bladder and kidney.

Authors:  M Poljakovic; M L Svensson; C Svanborg; K Johansson; B Larsson; K Persson
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

3.  Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.

Authors:  J J Martinez; M A Mulvey; J D Schilling; J S Pinkner; S J Hultgren
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

4.  Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.

Authors:  M A Mulvey; J D Schilling; S J Hultgren
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB.

Authors:  D J Klumpp; A C Weiser; S Sengupta; S G Forrestal; R A Batler; A J Schaeffer
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli.

Authors:  Joel D Schilling; Robin G Lorenz; Scott J Hultgren
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.

Authors:  J D Schilling; M A Mulvey; C D Vincent; R G Lorenz; S J Hultgren
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

8.  Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection.

Authors:  Chia-Suei Hung; Julie Bouckaert; Danielle Hung; Jerome Pinkner; Charlotte Widberg; Anthony DeFusco; C Gale Auguste; Robert Strouse; Solomon Langermann; Gabriel Waksman; Scott J Hultgren
Journal:  Mol Microbiol       Date:  2002-05       Impact factor: 3.501

Review 9.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

Authors:  Betsy Foxman
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

10.  Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli.

Authors:  Joel D Schilling; Steven M Martin; Chia S Hung; Robin G Lorenz; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

View more
  261 in total

1.  Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Corinne K Cusumano; Thomas J Hannan; James W Janetka; Scott J Hultgren
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

3.  Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life.

Authors:  Matthew R Parsek; Clay Fuqua
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

Review 4.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

5.  Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.

Authors:  Matthew G Blango; Matthew A Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

6.  Structure-based drug design and optimization of mannoside bacterial FimH antagonists.

Authors:  Zhenfu Han; Jerome S Pinkner; Bradley Ford; Robert Obermann; William Nolan; Scott A Wildman; Doug Hobbs; Tom Ellenberger; Corinne K Cusumano; Scott J Hultgren; James W Janetka
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

7.  Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children.

Authors:  Luciana Robino; Paola Scavone; Lucia Araujo; Gabriela Algorta; Pablo Zunino; María Catalina Pírez; Rafael Vignoli
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

8.  Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach.

Authors:  Swaine L Chen; Chia-Seui Hung; Jian Xu; Christopher S Reigstad; Vincent Magrini; Aniko Sabo; Darin Blasiar; Tamberlyn Bieri; Rekha R Meyer; Philip Ozersky; Jon R Armstrong; Robert S Fulton; J Phillip Latreille; John Spieth; Thomas M Hooton; Elaine R Mardis; Scott J Hultgren; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

9.  Persistence of uropathogenic Escherichia Coli in the bladders of female patients with sterile urine after antibiotic therapies.

Authors:  Shu-Cheng Liu; Xiao-Min Han; Ming Shi; Zi-Li Pang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

Review 10.  Urinary Tract Infection: Pathogenesis and Outlook.

Authors:  Lisa K McLellan; David A Hunstad
Journal:  Trends Mol Med       Date:  2016-09-28       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.